ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 700,88
0,50%
Dow Jones
39 112,16
-0,76%
DAX
18 351,41
1,04%
Brent Oil
84,415
0,27%
Bitcoin
61 450,72
-0,58%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV
  6. Quest PharmaTech Inc (QPT)

  7. Quest PharmaTech Inc (QPT) Actualités

QPT

Quest PharmaTech (QPT)

Quest PharmaTech Inc
De:
Trier par:
 Showing the most relevant articles for your search:TSXV:QPT
DateHeureSourceTitreSymboleSociété
30/05/202423h00PR Newswire (Canada)Quest PharmaTech Announces Filing of 2024 Year End Financial Statements and Restated Fiscal 2023 Financial Statements, and Appointment of New DirectorTSXV:QPTQuest PharmaTech Inc
30/01/202423h00PR Newswire (Canada)Quest Receives Cash Dividend Payment from OncoQuestTSXV:QPTQuest PharmaTech Inc
23/01/202423h49PR Newswire (Canada)Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical BenefitsTSXV:QPTQuest PharmaTech Inc
13/09/202322h15PR Newswire (Canada)Quest PharmaTech Provides Corporate UpdateTSXV:QPTQuest PharmaTech Inc
14/07/202322h30PR Newswire (Canada)Quest PharmaTech Announces Results from AGMTSXV:QPTQuest PharmaTech Inc
10/07/202322h30PR Newswire (Canada)Quest PharmaTech Provides Product Development UpdateTSXV:QPTQuest PharmaTech Inc
07/06/202313h52PR Newswire (Canada)L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - QPTTSXV:QPTQuest PharmaTech Inc
07/06/202313h50PR Newswire (Canada)Canadian Investment Regulatory Organization Trade Resumption - QPTTSXV:QPTQuest PharmaTech Inc
06/06/202323h15PR Newswire (Canada)Quest PharmaTech Clarifies Agreement in Principle with OQP Bio Inc.TSXV:QPTQuest PharmaTech Inc
06/06/202314h03PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - QPTTSXV:QPTQuest PharmaTech Inc
06/06/202314h00PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - QPTTSXV:QPTQuest PharmaTech Inc
28/09/202223h00PR Newswire (Canada)Quest PharmaTech Announces Sale of Bioceltran Investment and Return of Photodynamic Therapy Technology LicenseTSXV:QPTQuest PharmaTech Inc
01/09/202123h15PR Newswire (Canada)OncoQuest Pharmaceuticals Inc. Announces First Patient Enrolled in Each of Two Investigator Initiated Clinical Trials of Oregovomab in Combination Therapy for the Treatment of Recurrent Ovarian CancerTSXV:QPTQuest PharmaTech Inc
01/06/202121h00PR Newswire (Canada)Quest PharmaTech announces two presentations by OncoQuest Pharmaceuticals, Inc. at the 2021 Annual Meeting of the American As...TSXV:QPTQuest PharmaTech Inc
27/03/202100h14PR Newswire (Canada)Quest Provides Update to Immunotherapy Asset Transfer Between OncoQuest Inc. and OncoQuest Pharmaceuticals Inc.TSXV:QPTQuest PharmaTech Inc
09/11/202023h30PR Newswire (Canada)Quest Announces that OncoQuest Pharmaceuticals Inc. Doses First Patient in Phase 3 Clinical Trial, FLORA-5, of Company's Lead...TSXV:QPTQuest PharmaTech Inc
04/06/202023h05PR Newswire (Canada)Quest Provides Corporate UpdateTSXV:QPTQuest PharmaTech Inc
02/06/202022h11PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - QPTTSXV:QPTQuest PharmaTech Inc
02/06/202022h08PR Newswire (Canada)IIROC Trading Resumption - QPTTSXV:QPTQuest PharmaTech Inc
04/05/202017h16PR Newswire (Canada)MISE À JOUR - Suspension de la négociation par l'OCRCVM - QPTTSXV:QPTQuest PharmaTech Inc
04/05/202017h10PR Newswire (Canada)UPDATE - IIROC Trading Halt - QPTTSXV:QPTQuest PharmaTech Inc
01/05/202022h30PR Newswire (Canada)Quest PharmaTech Announces Results from its April 28, 2020 AGMTSXV:QPTQuest PharmaTech Inc
22/04/202019h10PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - QPTTSXV:QPTQuest PharmaTech Inc
22/04/202019h07PR Newswire (Canada)IIROC Trading Halt - QPTTSXV:QPTQuest PharmaTech Inc
22/04/202018h47PR Newswire (Canada)OncoQuest Signs a Definitive Agreement to Sell Drug Portfolio to Dual Industrial for U.S. $300 Million and Commitment to Fund...TSXV:QPTQuest PharmaTech Inc
24/03/202011h00PR Newswire (Canada)OncoQuest Announces Publication of Two Reports Related to Oregovomab Phase 2 Clinical Trial, the Company's Lead Investigation...TSXV:QPTQuest PharmaTech Inc
13/03/202022h01PR Newswire (Canada)OncoQuest Announces a U.S.$50 Million Investment by KOSDAQ listed Dual Industrial Co. Ltd.TSXV:QPTQuest PharmaTech Inc
25/09/201913h00PR Newswire (Canada)OncoQuest Receives "Notice of Allowance" for Patent Protection of the Administration Schedule of Oregovomab and Chemotherapy ...TSXV:QPTQuest PharmaTech Inc
25/01/201918h50PR Newswire (Canada)OncoQuest Lays the Groundwork for Commencement of Phase 3 Study in Frontline Ovarian CancerTSXV:QPTQuest PharmaTech Inc
20/12/201801h26PR Newswire (Canada)Quest PharmaTech Adopts Amendment to By-laws Requiring Advance Notice of Nomination of DirectorsTSXV:QPTQuest PharmaTech Inc
 Showing the most relevant articles for your search:TSXV:QPT

Dernières Valeurs Consultées

USOTC
MQBKY
Macquarie (PK)
TG
3920
Spyre Therapeutics
BIT
NSCIT0539089
Brera Sec Srl
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés